Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Rituximab Combined with Chemotherapy and Interferon in Follicular Lymphoma Patients: Final Analysis of the GELA-GOELAMS FL2000 Study with a 5-Year Follow-Up.

Gilles Andre Salles, MD, PhD, Nicolas Mounier, MD, PhD, Sophie de Guibert, MD, Franck Morschhauser, MD, Chantal Doyen, MD, Jean-Francois Rossi, MD, PhD, Corinne Haioun, MD, Pauline Brice, MD, Béatrice Mahé, MD, Reda Bouabdallah, MD, Bruno Audhuy, MD, Christophe Ferme, MD, Caroline Dartigeas, MD, Pierre Feugier, MD, Catherine Sebban, MD, Luc Xerri, MD, PhD, Charles Foussard, MD

Blood (2007) 110 (11): 792.

https://doi.org/10.1182/blood.V110.11.792.792

Published: 2007

Journal Articles

Consolidation Therapy with Subcutaneous Alemtuzumab Following Induction Treatment with Oral FC (Fludarabine and Cyclophosphamide) in Previously Untreated Patients Aged 65-70 Years with Advanced Stage Chronic Lymphocytic Leukemia (CLL): A Phase II Trial of the FCGCLL/MW.

Alain Delmer, MD, Stéphane Leprêtre, MD, Bruno Cazin, MD, Pierre Feugier, MD, PhD, Olivier Tournilhac, MD, PhD, Michel Leporrier, MD, Brigitte Dreyfus, MD, Béatrice Mahé, MD, Catherine Thieblemont, MD, PhD, Marine Divine, MD, Vincent Lévy, MD, PhD, Véronique Leblond, MD, Florence Cymbalista, MD, PhD, Rémy Letestu, MD, PhD

Blood (2006) 108 (11): 2831.

https://doi.org/10.1182/blood.V108.11.2831.2831

Published: 2006

Journal Articles

Treatment of Myelodysplastic Syndromes with del 5q before the Lenalidomide Era: The GFM Experience.

Charikleia Kelaidi, MD, Sophie Park, MD, Sabine Brechignac, MD, Lionel Mannone, MD, Norbert Vey, MD, Herve Dombret, MD, Lina Aljassem, MD, Aspasia Stamatoullas, MD, Lionel Adès, MD, Stéphane Giraudier, MD, Stéphane de Botton, MD, Béatrice Mahé, MD, Pascale Lepelley, MD, Françoise Picard, MD, Geneviève Leroux, MD, Marie-Thérèse Daniel, MD, Didier Bouscary, MD, François Dreyfus, MD, Pierre Fenaux, MD

Blood (2006) 108 (11): 2678.

https://doi.org/10.1182/blood.V108.11.2678.2678

Published: 2006

Journal Articles

Fludarabine Plus Cyclophosphamide and Rituximab (RFC) in Waldenström’s Macroglobulinemia (WM): Results in 21 Patients (pts).

Jacques Vargaftig, MD, Brigitte Pegourié-Bandelier, MD, Béatrice Mahé, MD, Steven Le Gouill, MD, PhD, Elisabeth Brottier-Mancini, MD, Richard Delarue, MD, Agnès Buzyn, MD, PhD, Martine Raphael, MD, Sylvain Choquet, MD, Véronique Leblond, MD

Blood (2006) 108 (11): 4727.

https://doi.org/10.1182/blood.V108.11.4727.4727

Published: 2006

Journal Articles

Lung Resection for Invasive Pulmonary Aspergillosis in Neutropenic Patients with Hematologic Malignancies: Long Term Results in Thirty Two Cases.

Thomas Gastinne, Cyril Touzeau, Stéphane Vigouroux, Steven Le Gouill, Béatrice Mahé, Viviane Dubruille, Jacques Delaunay, Patrice Chevalier, Thierry Guillaume, Christine Sagan, Françoise Gay-Andrieu, Patrick Germaud, Philippe Despins, Philippe Moreau, Jean-Luc Harousseau

Blood (2006) 108 (11): 2857.

https://doi.org/10.1182/blood.V108.11.2857.2857

Published: 2006

NARROW

Rituximab Combined with Chemotherapy and Interferon in Follicular Lymphoma Patients: Final Analysis of the GELA-GOELAMS FL2000 Study with a 5-Year Follow-Up.

Consolidation Therapy with Subcutaneous Alemtuzumab Following Induction Treatment with Oral FC (Fludarabine and Cyclophosphamide) in Previously Untreated Patients Aged 65-70 Years with Advanced Stage Chronic Lymphocytic Leukemia (CLL): A Phase II Trial of the FCGCLL/MW.

Treatment of Myelodysplastic Syndromes with del 5q before the Lenalidomide Era: The GFM Experience.

Fludarabine Plus Cyclophosphamide and Rituximab (RFC) in Waldenström’s Macroglobulinemia (WM): Results in 21 Patients (pts).

Lung Resection for Invasive Pulmonary Aspergillosis in Neutropenic Patients with Hematologic Malignancies: Long Term Results in Thirty Two Cases.

Email alerts

ASH Publications

American Society of Hematology

Rituximab Combined with Chemotherapy and Interferon in Follicular Lymphoma Patients: Final Analysis of the GELA-GOELAMS FL2000 Study with a 5-Year Follow-Up.

Consolidation Therapy with Subcutaneous Alemtuzumab Following Induction Treatment with Oral FC (Fludarabine and Cyclophosphamide) in Previously Untreated Patients Aged 65-70 Years with Advanced Stage Chronic Lymphocytic Leukemia (CLL): A Phase II Trial of the FCGCLL/MW.

Treatment of Myelodysplastic Syndromes with del 5q before the Lenalidomide Era: The GFM Experience.

Fludarabine Plus Cyclophosphamide and Rituximab (RFC) in Waldenström’s Macroglobulinemia (WM): Results in 21 Patients (pts).

Lung Resection for Invasive Pulmonary Aspergillosis in Neutropenic Patients with Hematologic Malignancies: Long Term Results in Thirty Two Cases.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only